# Secreted Phosphoprotein 1 (SPP1) Modulates Intracellular Metabolic Programs in Mature Adipocytes Revealed by Untargeted Metabolomics

**Authors:** Young Hwa Kim, Aejin Lee

PMC · DOI: 10.3390/ijms27041639 · International Journal of Molecular Sciences · 2026-02-08

## TL;DR

This study shows how different amounts of SPP1 affect metabolism in fat cells, with low doses causing more metabolic changes than high doses.

## Contribution

The study reveals SPP1's novel role in modulating intracellular metabolic programs in mature adipocytes using untargeted metabolomics.

## Key findings

- Low-dose SPP1 (100 ng/mL) caused more pronounced intracellular metabolic remodeling than high-dose SPP1 (500 ng/mL).
- Low-dose SPP1 altered carbohydrate- and amino acid-related metabolic pathways, including the pentose phosphate pathway and alanine metabolism.
- High-dose SPP1 selectively induced matrix metalloproteinase-12 (MMP-12), indicating remodeling-associated responses.

## Abstract

Secreted phosphoprotein 1 (SPP1), also known as osteopontin (OPN), is a multifunctional secreted factor implicated in inflammatory remodeling of adipose tissue. Here, we applied untargeted liquid chromatography–mass spectrometry (LC–MS)-based metabolomics to examine how different concentrations of SPP1 influence metabolism in differentiated 3T3-L1 adipocytes. We found that low-dose SPP1 (100 ng/mL) was associated with more pronounced intracellular metabolic remodeling than higher-dose SPP1 (500 ng/mL). Multivariate analyses, including principal component analysis (PCA), partial least squares–discriminant analysis (PLS-DA), and sparse PLS-DA, revealed a distinct metabolic profile in the low-dose group, whereas the high-dose group showed a comparatively attenuated metabolic response. Pathway enrichment analysis identified alterations in carbohydrate- and amino acid-related metabolic networks, including the pentose phosphate pathway; pentose and glucuronate interconversions; and alanine, aspartate, and glutamate metabolism. In contrast, higher-dose SPP1 was associated with selective induction of matrix metalloproteinase-12 (MMP-12), suggesting the engagement of remodeling-associated responses at elevated SPP1 levels. Together, these findings identify SPP1 as a modulator of metabolic programs in mature adipocytes and highlight its capacity to influence intracellular metabolic remodeling.

## Linked entities

- **Proteins:** SPP1 (secreted phosphoprotein 1), MMP12 (matrix metallopeptidase 12)

## Full-text entities

- **Genes:** AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, Ccl5 (C-C motif chemokine ligand 5) [NCBI Gene 20304] {aka MuRantes, RANTES, SISd, Scya5, TCP228}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Ccl2 (C-C motif chemokine ligand 2) [NCBI Gene 20296] {aka HC11, JE, MCAF, MCP-1, MCP1, SMC-CF}, KRT16 (keratin 16) [NCBI Gene 3868] {aka CK16, FNEPPK, K16, K1CP, KRT16A, NEPPK}, Adipoq (adiponectin, C1Q and collagen domain containing) [NCBI Gene 11450] {aka 30kDa, APN, Acdc, Acrp30, Ad, Adid}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Retn (resistin) [NCBI Gene 57264] {aka ADSF, Fizz3, Rstn, Xcp4}, Mmp2 (matrix metallopeptidase 2) [NCBI Gene 17390] {aka Clg4a, GelA, MMP-2}, MMP2 (matrix metallopeptidase 2) [NCBI Gene 4313] {aka CLG4, CLG4A, MMP-2, MMP-II, MONA, TBE-1}, Mmp9 (matrix metallopeptidase 9) [NCBI Gene 17395] {aka B/MMP9, Clg4b, Gel B, MMP-9, pro-MMP-9}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, KRT6A (keratin 6A) [NCBI Gene 3853] {aka CK-6C, CK-6E, CK6A, CK6C, CK6D, K6A}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 5295] {aka AGM7, GRB1, IMD36, p85, p85-ALPHA, p85alpha}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, TIMP1 (TIMP metallopeptidase inhibitor 1) [NCBI Gene 7076] {aka CLGI, EPA, EPO, HCI, TIMP, TIMP-1}, Il16 (interleukin 16) [NCBI Gene 16170] {aka mKIAA4048}, Mmp12 (matrix metallopeptidase 12) [NCBI Gene 17381] {aka MME, Mmel}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Timp1 (tissue inhibitor of metalloproteinase 1) [NCBI Gene 21857] {aka Clgi, EPA, TIMP-1, TPA-S1, Timp}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, MMP12 (matrix metallopeptidase 12) [NCBI Gene 4321] {aka HME, ME, MME, MMP-12}, Gdf15 (growth differentiation factor 15) [NCBI Gene 23886] {aka MIC-1, NAG-1, SBF}, G6PD (glucose-6-phosphate dehydrogenase) [NCBI Gene 2539] {aka CNSHA1, G6PD1}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}
- **Diseases:** SL (MESH:C564794), Inflammatory (MESH:D007249), injury to (MESH:D014947), resistant (MESH:D060467), obesity (MESH:D009765), metabolic diseases (MESH:D008659), impaired insulin sensitivity (MESH:D007333), adipose (MESH:D018205)
- **Chemicals:** methanol (MESH:D000432), formic acid (MESH:C030544), nitrogen (MESH:D009584), ethychlozate (MESH:C458560), hopantenic acid (MESH:C016030), pentose phosphate (MESH:D010428), alanine (MESH:D000409), Streptomycin (MESH:D013307), carbon (MESH:D002244), acetonitrile (MESH:C032159), tyrosine (MESH:D014443), water (MESH:D014867), Oil Red O (MESH:C011049), Rebimastat (MESH:C422302), glutamate (MESH:D018698), p-nitroacetophenone (MESH:C001972), pentose (MESH:D010429), prednisolone hemisuccinate (MESH:C021322), I7018 (-), glucuronate (MESH:D020723), Penicillin (MESH:D010406), 3-isobutyl-1-methyl xanthine (MESH:D015056), Amino Acid (MESH:D000596), droxidopa (MESH:D015103), NADP (MESH:D009249), aspartate (MESH:D001224), dexamethasone (MESH:D003907), Carbohydrate (MESH:D002241), ammonium bicarbonate (MESH:C027043), dimethyl sulfate (MESH:C007482), Lipid (MESH:D008055), tryptophan (MESH:D014364), reactive oxygen species (MESH:D017382), glucose (MESH:D005947)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** 3T3-L1 — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_0123), SH — Trichoplusia ni (Cabbage looper), Spontaneously immortalized cell line (CVCL_C190)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940543/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940543/full.md

## References

23 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940543/full.md

---
Source: https://tomesphere.com/paper/PMC12940543